Quarterly Call Option Transactions in Recursion Pharmaceuticals, Inc. (RXRX)
This table provides information about the institutional ownership of Recursion Pharmaceuticals, Inc. (RXRX) during . The information is specifically focused on institutions that hold call options of RECURSION PHARMACEUTICALS, INC..
Calls Purchased
Calls Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 0 | 16,700 | 16,700 | 2,100 | 0 | 2,100 | 14,600 | |
| Q4 2021 | — | 0 | 11,500 | 11,500 | -11,500 | |||
| Q1 2022 | — | — | 0 | |||||
| Q2 2022 | 10,000 | 0 | 10,000 | — | 10,000 | |||
| Q3 2022 | 36,600 | 0 | 36,600 | 9,800 | 0 | 9,800 | 26,800 | |
| Q4 2022 | 100 | 0 | 100 | 53,200 | 0 | 53,200 | -53,100 | |
| Q1 2023 | 36,000 | 0 | 36,000 | — | 36,000 | |||
| Q2 2023 | 30,600 | 0 | 30,600 | — | 30,600 | |||
| Q3 2023 | 204,500 | 122,000 | 326,500 | — | 326,500 | |||
| Q4 2023 | 131,800 | 25,600 | 157,400 | — | 157,400 | |||
| Q1 2024 | 258,900 | 56,303 | 315,203 | — | 315,203 | |||
| Q2 2024 | 158,600 | 68,000 | 226,600 | 25,901 | 0 | 25,901 | 200,699 | |
| Q3 2024 | 392,800 | 117,000 | 509,800 | 68,300 | 0 | 68,300 | 441,500 | |